WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010030722) GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/030722    International Application No.:    PCT/US2009/056436
Publication Date: 18.03.2010 International Filing Date: 10.09.2009
IPC:
C07D 215/18 (2006.01), C07D 217/22 (2006.01), A61K 31/404 (2006.01), C07D 215/227 (2006.01), C07D 217/24 (2006.01), C07D 239/70 (2006.01), C07D 403/04 (2006.01), C07D 413/04 (2006.01)
Applicants: MERCK SHARP & DOHME CORP. [US/US]; 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 (US) (For All Designated States Except US).
LIN, Songnian [US/US]; (US) (For US Only).
STEVENSON, Christian, P. [US/US]; (US) (For US Only).
PARMEE, Emma, R. [US/US]; (US) (For US Only).
XU, Libo [US/US]; (US) (For US Only).
LIAO, Xibin [CN/US]; (US) (For US Only).
METZGER, Edward [US/US]; (US) (For US Only).
LIANG, Rui [US/US]; (US) (For US Only).
ZHANG, Fengqi [US/US]; (US) (For US Only).
STELMACH, John, E. [US/US]; (US) (For US Only)
Inventors: LIN, Songnian; (US).
STEVENSON, Christian, P.; (US).
PARMEE, Emma, R.; (US).
XU, Libo; (US).
LIAO, Xibin; (US).
METZGER, Edward; (US).
LIANG, Rui; (US).
ZHANG, Fengqi; (US).
STELMACH, John, E.; (US)
Common
Representative:
MERCK SHARP & DOHME CORP.; 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 (US)
Priority Data:
61/192,080 15.09.2008 US
Title (EN) GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
(FR) COMPOSÉS ANTAGONISTES DU RÉCEPTEUR DU GLUCAGON, COMPOSITIONS CONTENANT CES COMPOSÉS ET MÉTHODES D'UTILISATION
Abstract: front page image
(EN)Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
(FR)La présente invention concerne des composés antagonistes du récepteur du glucagon. Ces composés sont utiles pour traiter le diabète de type 2 et les maladies apparentées. Des compositions pharmaceutiques et des méthodes de traitement sont également décrites.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)